BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14674372)

  • 1. Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update.
    Pomara N; Greenberg WM; Branford MD; Doraiswamy PM
    Psychopharmacol Bull; 2003; 37(2):120-34. PubMed ID: 14674372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease.
    Elgh E; Lindqvist Astot A; Fagerlund M; Eriksson S; Olsson T; Näsman B
    Biol Psychiatry; 2006 Jan; 59(2):155-61. PubMed ID: 16125145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stress system in depression and neurodegeneration: focus on the human hypothalamus.
    Bao AM; Meynen G; Swaab DF
    Brain Res Rev; 2008 Mar; 57(2):531-53. PubMed ID: 17524488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review.
    de Kloet CS; Vermetten E; Geuze E; Kavelaars A; Heijnen CJ; Westenberg HG
    J Psychiatr Res; 2006 Sep; 40(6):550-67. PubMed ID: 16214171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Depression, stress and brain function].
    Videbech P; Petersen TH
    Ugeskr Laeger; 2001 Nov; 163(47):6568-72. PubMed ID: 11760536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids and cognitive function: from physiology to pathophysiology.
    Jameison K; Dinan TG
    Hum Psychopharmacol; 2001 Jun; 16(4):293-302. PubMed ID: 12404564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the hypothalamic-pituitary-adrenal/gonadal axes on trajectory of age-related cognitive decline.
    Conrad CD; Bimonte-Nelson HA
    Prog Brain Res; 2010; 182():31-76. PubMed ID: 20541660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limbic and HPA axis function in an animal model of chronic neuropathic pain.
    Ulrich-Lai YM; Xie W; Meij JT; Dolgas CM; Yu L; Herman JP
    Physiol Behav; 2006 Jun; 88(1-2):67-76. PubMed ID: 16647726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL; Liberzon I; Young EA; Khan S
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.
    O'Brien JT; Ames D; Schweitzer I; Colman P; Desmond P; Tress B
    Br J Psychiatry; 1996 Jun; 168(6):679-87. PubMed ID: 8773809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPA- and HPT-axis alterations in chronic posttraumatic stress disorder.
    Olff M; Güzelcan Y; de Vries GJ; Assies J; Gersons BP
    Psychoneuroendocrinology; 2006 Nov; 31(10):1220-30. PubMed ID: 17081699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
    Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
    Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets.
    Caraci F; Copani A; Nicoletti F; Drago F
    Eur J Pharmacol; 2010 Jan; 626(1):64-71. PubMed ID: 19837057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypothalamic-pituitary-adrenal axis in borderline personality disorder: a review.
    Zimmerman DJ; Choi-Kain LW
    Harv Rev Psychiatry; 2009; 17(3):167-83. PubMed ID: 19499417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
    Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.
    Tanriverdi F; Karaca Z; Unluhizarci K; Kelestimur F
    Stress; 2007 Mar; 10(1):13-25. PubMed ID: 17454963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.